Haleon (XTER:H6D0) Interest Expense : €-528 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Haleon's interest expense for the three months ended in Mar. 2024 was € -113 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was €-528 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Haleon's Operating Income for the three months ended in Mar. 2024 was € 766 Mil. Haleon's Interest Expense for the three months ended in Mar. 2024 was € -113 Mil. Haleon's Interest Coverage for the quarter that ended in Mar. 2024 was 6.75. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Haleon Interest Expense Historical Data

The historical data trend for Haleon's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Interest Expense Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

-30.67

-16.57

-18.83

-319.65

-480.55

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial									-107.68	-144.51	-102.05	-168.31	-113.39

Haleon Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-528 Mil.

Haleon (XTER:H6D0) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Haleon's Interest Expense for the three months ended in Mar. 2024 was €-113 Mil. Its Operating Income for the three months ended in Mar. 2024 was €766 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was €0 Mil.

Haleon's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	765.693	/	-113.393
	=	6.75

The higher the ratio, the stronger the company's financial strength is.

Haleon (XTER:H6D0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (XTER:H6D0) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLN:USA HLN1:Mexico HLNl:UK HLN:UK

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Haleon (XTER:H6D0) Headlines

No Headlines